Novavax Inc (NVAX) stock

NVAXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/30

$8.53−0.23 (-2.68%)

Close on Nov 13, 2026Market cap $1.41BP/E –Yield –

Novavax statistics

79 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings: Feb 25, 2027 (estimated, before the open)
Last ex-dividend date: No dividends
Fundamentals through: Sep 30, 2026
Share price as of: Nov 13, 2026

Valuation ratiosIndustry

Market Cap: $1.41B; $272.32M
Enterprise Value: $783.80M; $146.23M
PS Ratio: 3.42; 3.66

Enterprise valuationIndustry

EV / Sales: 1.90; 2.57

Share statisticsIndustry

Shares Outstanding: 165M; 58M
Shares Change (YoY): 0.46%; 10.8%
Shares Change (QoQ): 0.11%; 0.50%
Float: 150M; 49M
Shares Held by Insiders: 9.19%; 11.7%
Shares Held by Institutions: 71.2%; 56.4%

Short sellingIndustry

Short Interest: 46M; –
Short Interest Change: -2.15%; -0.80%
Short % of Float: 30.9%; 9.01%
Short % of Shares Outstanding: 28.1%; 6.30%
Days to Cover: 7.61; 5.15

Stock price statisticsIndustry

52-Week High: $13.38; –
52-Week Low: $6.20; –
20-Day Moving Average: $10.10; –
50-Day Moving Average: $10.54; –
200-Day Moving Average: $9.33; –
Average True Range (14): $0.86; –
Price Change (1 Week): -20.9%; -1.15%
Price Change (1 Month): -33.5%; -4.87%
Price Change (3 Months): 5.64%; -21.0%
Price Change (6 Months): -5.91%; -20.6%
Price Change (YTD): 26.9%; -23.6%
Price Change (1 Year): 18.4%; -22.4%
Price Change (3 Years): 36.6%; -29.5%
Price Change (5 Years): -95.0%; -77.9%
Price Change (10 Years): -68.4%; -65.4%
Average Volume (10 Days): 7M; –
Average Volume (20 Days): 6M; –
Average Volume (90 Days): 6M; –
Relative Volume: 0.81; 0.70
Relative Strength Index (14): 37.6; 43.4
Volatility (1 Year): 73.5%; 80.1%
Beta (5 Years): 1.92; 1.07

MarginsIndustry

Gross Margin: 78.0%; 53.1%
Operating Margin: -21.2%; -38.7%
Pretax Margin: -17.5%; -11.6%
Profit Margin: -18.6%; -31.6%
EBITDA Margin: -17.7%; -27.7%

Returns on capitalIndustry

Return on Assets (ROA): -7.42%; -40.6%
Return on Capital Employed (ROCE): -15.7%; -37.9%

Financial positionIndustry

Current Ratio: 2.15; 3.30
Quick Ratio: 2.04; 2.39
Interest Coverage: -4.01; -6.35

GrowthIndustry

Revenue Growth (YoY): -61.3%; 6.82%
Net Income Growth (YoY): -122.5%; -14.4%
EPS Growth (YoY): -126.8%; -12.3%
Revenue Growth (3Y CAGR): -17.2%; 2.25%
Revenue Growth (5Y CAGR): 18.8%; 6.41%

EfficiencyIndustry

Asset Turnover: 0.40; 0.40
Inventory Turnover: 5.66; 2.73
Revenue Per Employee: $549.60K; $429.29K
Profits Per Employee: -$102.44K; -$689.41K
Employee Count: 749; 74
WACC: 14.7%; 10.2%

Income statement (TTM)Industry

Revenue: $411.65M; $66.37M
Gross Profit: $321.12M; $120.78M
Operating Income: -$87.39M; -$21.37M
Pretax Income: -$71.93M; -$12.95M
Net Income: -$76.73M; -$22.35M
EBITDA: -$72.71M; -$17.21M
EPS (Diluted): -$0.48; -$0.76

Balance sheetIndustry

Cash & Short-Term Investments: $622.36M; $68.68M
Net Cash (Debt): $622.36M; $17.76M
Net Cash Per Share: $3.77; $0.80
Equity (Book Value): -$216.86M; $53.89M
Book Value Per Share: -$1.31; $1.50
Tangible Book Value: -$328.93M; $27.13M
Working Capital: $378.11M; $79.99M

Cash flow (TTM)Industry

Operating Cash Flow: -$238.95M; -$12.38M

Dividends and yieldsIndustry

Earnings Yield: -5.46%; -21.8%

Taxes and interestIndustry

Interest Expense: $21.82M; $2.90M
Income Tax: $4.79M; $73.00K

Scores and fair valueIndustry

Altman Z-Score: -5.94; 0.23
Piotroski F-Score: 6; 4
Beneish M-Score: 0.44; -2.63

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.

Period	NVAX	S&P 500	Difference	NVAX per year	S&P 500 per year
1 month	-33.5%	-3.0%	−30.5 pts
3 months	+4.7%	-2.8%	+7.5 pts
Year to date	+26.9%	+11.5%	+15.4 pts
1 year	+20.8%	+13.5%	+7.3 pts
3 years	+36.0%	+77.7%	−41.7 pts	+10.8%	+21.1%
5 years	-95.0%	+72.6%	−167.6 pts	-45.0%	+11.5%
10 years	-69.3%	+308.2%	−377.5 pts	-11.1%	+15.1%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

46M NVAX shares were sold short on Oct 30, 2026, down 2.2% from the previous report, or 30.93% of the shares available to trade. At recent volumes it would take 7.6 days to buy them back. Over the last 20 sessions, 52.1% of the volume reported to FINRA was short selling.

Settlement date	Shares short	Change	Avg. daily volume	Days to cover
Oct 30, 2026	46,329,834	-2.2%	6,090,855	7.6
Oct 15, 2026	47,348,523	+2.8%	10,919,148	4.3
Sep 30, 2026	46,046,946	-7.7%	5,714,870	8.1
Sep 15, 2026	49,875,210	+2.2%	5,372,798	9.3
Aug 31, 2026	48,784,134	+2.7%	5,663,047	8.6
Aug 14, 2026	47,494,355	+4.0%	3,384,229	14.0
Jul 31, 2026	45,659,491	+4.2%	2,746,393	16.6
Jul 15, 2026	43,821,227	-4.3%	3,835,115	11.4
Jun 30, 2026	45,809,886	+1.5%	4,935,619	9.3
Jun 15, 2026	45,113,281	-1.9%	4,181,161	10.8
May 29, 2026	45,965,363	+1.5%	5,866,242	7.8
May 15, 2026	45,278,456	-8.5%	7,134,181	6.3